XJPX
6988
Market cap14bUSD
Oct 09, Last price
3,615.00JPY
1D
2.52%
1Q
13.22%
Jan 2017
-59.69%
Name
Nitto Denko Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in Osaka, Japan, in 1918, Nitto Denko Corporation is a global company primarily recognized for its extensive adhesive tape operations. Its comprehensive product portfolio spans a variety of adhesive tapes, including double-sided, masking, and packaging options, alongside surface protective films, sealing and NVH materials, and specialized components for FPD/touch panel applications. The company further produces gasket materials, products essential for semiconductor manufacturing processes, flexible printed circuit boards, and various porous or breathable films. Beyond these, Nitto Denko supplies complete functional thermal transfer systems (comprising labels, barcode printers, and software), tapes specifically designed for electrical and electronic equipment, and solutions for cleanroom dust removal. Their offerings also extend to fluoroplastic sheets, tapes, and porous films, materials for housing and construction, and packaging machinery. Additionally, the company plays a role in the medical sector, providing transdermal therapeutic systems, athletic tapes, medical adhesive tapes for wearable devices and body sensors, and particles utilized in nucleic acid synthesis. These wide-ranging products are distributed across numerous industries, including automotive, transportation, housing, infrastructure, materials, home appliance, electrical, display, electronic device, medical, packaging, and consumer/personal care.
Key people
Hideo Takasaki
Chairman of the Board, Chief Executive Officer, Representative Director · since 2026
Yasuhito Ohwaki
Senior Managing Executive Officer, Chief Human Resources Officer, Chief Director of Corporate Human Resources, Director · since 2024
Seiji Fujioka
Managing Executive Officer, Manager of South Asia, India, and Oceania · since 2024
Yukihiro Horikawa
Managing Executive Officer, Manager of Human Life Solutions Business, Manager of North America and South America Area · since 2024
Sam Strijckmans
Managing Executive Officer, Manager of EMEA (Europe, Middle East, Africa) Area · since 2021
Kazuki Tsuchimoto
Managing Executive Officer, Chief Director of Quality Assurance · since 2025
Nobuyuki Aoki
Senior Executive Officer · since 2022
Kenjiro Asuma
Senior Executive Officer, Manager of Taiwan Area, Chairman and General Manager of Subsidiary · since 2024
Yasuhiro Hayashi
Senior Executive Officer, Chief Director of Legal & Compliance · since 2023
Katsuyoshi Jo
Senior Executive Officer · since 2022
Bae-Won Lee
Senior Executive Officer, Manager of Korea Area · since 2021
Norio Sato
Senior Executive Officer, Director of Advanced Film Solutions Business · since 2021
Atsushi Ukon
Senior Executive Officer · since 2021
Naoki Makino
Executive Officer, Chief Director of Sales · since 2024
Michihiro Hagiwara
Executive Officer, Chief Director of Quality Assurance · since 2023
Hitoki Kanagawa
Executive Officer, Assistant Manager of Information Functional Materials Unit · since 2022
Hiroyuki Katayama
Executive Officer, Manager of Membrane Business in Human Life Solutions Sector · since 2023
Junichi Matsumoto
Executive Officer, Chief Director of Procurement Business · since 2023
Nao Murakami
Executive Officer, Chief Director of New business for Company-wide Technology Unit · since 2022
Kei Nakamura
Executive Officer, Chief Director of Company-wide Technology in Research and Development Unit, Chief Director of Digital Promotion · since 2025
Legal address
下穂積1丁目1番2号
大阪府 茨木市 567-8680
JP
大阪府 茨木市 567-8680
JP
Headquarters
北区大深町4番20号 グランフロント大阪 タワーA 33階
大阪府 大阪市 530-0011
JP
大阪府 大阪市 530-0011
JP
Address
1-1-2, Shimohozumi
Ibaraki Osaka 567-8680
JP
Ibaraki Osaka 567-8680
JP
Address
33rd Floor, Grand Front Osaka, 4-20, Ofuka-cho, Kita-ku
Osaka Osaka 530-0011
JP
Osaka Osaka 530-0011
JP
Other language
Nitto Denko Corporation
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||